5-(4-CHLOROPHENYL)-1-(2-METHOXYPHENYL)-1H-PYRAZOL-3(2H)-ONE, 95.0%, 100mg

Ethyl 2-aminothiophene-3-carboxylate, 97.0%, 100g

(5S,8S,10aR)-3-((Benzyloxy)carbonyl)-5-((tert-butoxycarbonyl)amino)-6-oxodecahydropyrrolo[1,2-a][1,5]diazocine-8-carboxylic acid, 97%, 250mg

(S,E)-N-(4-((3,4-DICHLOROPHENYL)AMINO)-7-((TETRAHYDROFURAN-3-YL)OXY)QUINAZOLIN-6-YL)-4-(DIMETHYLAMINO)BUT-2-ENAMIDE, 95%, 50mg

Trial kit Spectra/Por® Biotech CE, 100000 dalton(s), 1 Piece(s)

N-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole-1-acetamide, 98%, 250mg

2'-Amino-5'-methyl-[1,1':3',1''-terphenyl]-3,3'',5,5''-tetracarboxylic acid, 98%, 250mg

1,6,7,12-Tetrachloroperylenetetracarboxylic acid dianhydride, 95.0%, 10g

4-iodo-1-(4-methoxybenzyl)-1H-pyrazole, 95.0%, 1g

4-Cyano-3-nitrobenzoic acid, 98%, 250mg

4,4''-Dibromo-1,1':3',1''-terphenyl, 98%, 1g

(1-Methyl-5-phenyl-1H-pyrazol-4-yl)boronic acid, 95.0%, 5g

2-Fluoro-5-methylpyridine, 99.0%, 25g